Navigation Links
Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
Date:5/19/2009

ally significant and clinically meaningful effect on both the primary endpoint of change in percent predicted FVC and secondary endpoints of progression-free survival and categorical change in percent predicted FVC. While CAPACITY 1 did not achieve statistical significance on the primary endpoint, the results were generally consistent with and supportive of CAPACITY 2. Further, the treatment effect observed in the CAPACITY studies was generally consistent with that observed in the Phase 3 study of pirfenidone in IPF patients conducted by Shionogi & Co. Ltd. in Japan."

Dr. Roland du Bois, Professor of Medicine at National Jewish Health, Denver, Colo., and CAPACITY co-chair also commented on the CAPACITY results. "When taken in the context of the urgent unmet medical need for new medicines to treat IPF patients, the collective efficacy and safety data from the two CAPACITY studies, corroborated by a similar study in Japan, make a case for the use of pirfenidone in this disease setting."

Primary Efficacy Endpoint Results

The primary endpoint of both CAPACITY studies was change in percent predicted Forced Vital Capacity (FVC) after 72 weeks of treatment, evaluated with a nonparametric rank ANCOVA. In the CAPACITY 2 study, the primary endpoint was met (p=0.001). In CAPACITY 1, the primary endpoint was not met (p=0.501). An exploratory analysis of pooled primary endpoint data from both studies using the pre-specified primary endpoint test statistic from a nonparametric rank ANCOVA resulted in a P value of 0.005.

A pre-specified repeated measures analysis of the primary endpoint was used to obtain a least squares mean estimate (LS mean) of the magnitude of the treatment effect. The LS mean change in percent predicted FVC at Week 72 was -6.5% and -9.6% in the pirfenidone and placebo groups, respectively, in CAPACITY 2, and -6.5% and -7.2%, respectively, in CAPACITY 1. This represents
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
4. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
5. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
6. AlphaVax Announces Promising Results in Melanoma Studies
7. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
8. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
9. Bionovo Announces First Quarter 2009 Highlights and Financial Results
10. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
11. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... CVS Health Corporation (NYSE: CVS ) ... 1, 2015, at 8:30 a.m. (EDT) with analysts and ... An audio webcast of the conference call will ... the CVS Health website for all interested parties. To ... will be archived and available on the web site ...
(Date:4/17/2015)... SAN DIEGO , April 17, 2015 /PRNewswire/ ... molecular diagnostics, announced today that clinical data presented ... demonstrate that its urine-based Precision Cancer Monitoring ℠ ... detection and monitoring of EGFR T790M ... titled Detection of EGFR T790M Mutation in ...
(Date:4/17/2015)... 2015  Over the next five years, the marijuana industry ... ArcView predicting that 14 more states will legalize recreational marijuana ... market for legal cannabis grew 74 percent in 2014 to ... the market could grow more than fourfold to $11 billion ... stance on marijuana. Cannabiz Mobile Inc. (OTCBB: LGBI) ...
Breaking Medicine Technology:Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2
... discovery of two explosive devices at East Midlands and Dubai ... the aviation networks by terrorism. One of the bombs posted ... before being seized in Dubai, Qatar Airways has said. The ... Doha. It contained the powerful explosive PETN, which is difficult ...
... Medisafe 1 Technologies, Presentation on Newly Launched Company Website -- JERUSALEM, November 8, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
Cached Medicine Technology:Marken Rapidly Responds to Global Supply Chain Security Measures 2Medisafe 1 Technologies' Presentation on Newly Launched Company Website 2Medisafe 1 Technologies' Presentation on Newly Launched Company Website 3Medisafe 1 Technologies' Presentation on Newly Launched Company Website 4Medisafe 1 Technologies' Presentation on Newly Launched Company Website 5Medisafe 1 Technologies' Presentation on Newly Launched Company Website 6Medisafe 1 Technologies' Presentation on Newly Launched Company Website 7Medisafe 1 Technologies' Presentation on Newly Launched Company Website 8
(Date:4/19/2015)... 19, 2015 Women’s Excellence , ... Metamora (Michigan), now offers pelvic organ prolapse treatment. ... connecting tissue (fascia), and thickened pieces of fascia that ... the fascia and ligaments have to bear the brunt ... allowing pelvic organs to drop and press into the ...
(Date:4/19/2015)... The American Association for Physician Leadership® ... the inaugural winner of the Roger Schenke Award. The ... 18, in Las Vegas, Nevada. , Ellner, president ... the department of surgery and director of surgical quality ... Connecticut, was instrumental in the founding of the Connecticut ...
(Date:4/19/2015)... Lowcostcarinsuranceprice.com has released a new blog post ... arrested for DUI. The blog post also discusses the ... , Some pills can have dangerous side effects ... are under medication should ask their doctor’s advice before ... be considered driving under the influence and clients can ...
(Date:4/19/2015)... New court documents issued by the ... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) continue to mount in ... of South Carolina. According to the April 15th filing, ... the proceeding on behalf of individuals who allegedly developed ... cholesterol-lowering statin. This represents an increase of 110 filings ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 McCann Investigations, ... to announce the publication of white paper Married, ... . As online media provides a unique environment ... niche market specifically targeting adulterous spouses has emerged. ... affair becomes as easy as shopping online. Dating ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Offers Pelvic Organ Prolapse Treatment 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 3Health News:Driving On Medication - Possible Effects On Auto Insurance Prices 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 3Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2
... has negatively affected the treatment received by children and adolescents ... The meeting was hosted in association with the European Society ... hurdles faced by patients and those who care for them ... The Directive (2001/20/EC) has been one of the most ...
... 2012) The Scott & White Heart & Vascular Institute ... of Approval as a hospital performing Ventricular Assist Device ... permanent support for end stage heart failure by means ... the program demonstrated compliance with The Joint Commission,s national ...
... Gordon HealthDay Reporter , TUESDAY, Feb. 14 ... doesn,t speed recovery, new research shows. "We did ... diagnosis of acute sinusitis, and found no benefit from ... of acute sinusitis," said study author Dr. Jane Garbutt, ...
... , TUESDAY, Feb. 14 (HealthDay News) -- People who drank ... to 5 pounds over half a year, according to new ... divided into three groups: those who switched to water from ... those who weren,t advised to change beverages but were given ...
... , Blood tests have been a mainstay of diagnostic ... of information concerning health and disease. Nevertheless, blood derived ... fully mined for its vital health information, according to ... Institute. In a new study appearing in the ...
... in the field of Physical Anthropology. She not only ... Czech Republic, but she is also the Chair of ... the Department of Genetics, Physical Anthropology and Animal Physiology ... carried out numerous pieces of work into nutritional habits, ...
Cached Medicine News:Health News:Calls for policy changes as lives put at risk by bureaucracy 2Health News:Calls for policy changes as lives put at risk by bureaucracy 3Health News:Antibiotics Don't Help Most Sinus Infections, Study Finds 2Health News:Antibiotics Don't Help Most Sinus Infections, Study Finds 3Health News:Switching to Water, Diet Drinks Linked to Modest Weight Loss 2Health News:Following a trail of blood: A new diagnostic tool comes of age 2Health News:Following a trail of blood: A new diagnostic tool comes of age 3Health News:Analyzing the causes of obesity in the Romani ethnic group 2Health News:Analyzing the causes of obesity in the Romani ethnic group 3
... V measures prompt ... luminescence, time-resolved ... A red-sensitive PMT ... All technologies needed ...
This a new dedicated VICTOR2 model for fluorescence and luminescence detection with stacker and robotic loading....
... is the modular VICTOR2 ... high density TR-fluorometry, stacker ... The extra high density ... excitation beam for TRF ...
This is the modular manually operated VICTOR2 multilabel counter, with the addition of a xenon flash lamp for time-resolved fluorescence counting. Along with this option comes flash absorbance and du...
Medicine Products: